OvaScience shares up on 1st birth after its fertility treatment

OvaScience gains after reported the birth of the 1st baby resulting from its Augment fertility treatment.

(Reuters) — Shares in OvaScience (NSDQ:OVAS) were up 8% at 1 point today after the company announced the 1st birth of baby resulting from its experimental Augment fertility treatment.

Organovo

News Well, Obstetrics, Stem Cells

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1P4hx69